A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment strategies are desperately needed due to limited standard therapies. Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC. The Se,Se′-1,4-phenylenebis(1,2-ethanediyl) bisisoselen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagaram, Hephzibah Rani S., Desai, Dhimant, Li, Guangfu, Liu, Dai, Rountree, C. Bart, Gowda, Kavitha, Berg, Arthur, Amin, Shantu, Staveley-O’Carroll, Kevin F., Kimchi, Eric T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932536/
https://www.ncbi.nlm.nih.gov/pubmed/27023566
http://dx.doi.org/10.3390/ph9020018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932536/
https://www.ncbi.nlm.nih.gov/pubmed/27023566
http://dx.doi.org/10.3390/ph9020018

Ejemplares similares